首页> 外文期刊>Journal of Molecular Structure >Reactions of 2,3-dichloro-1,4-naphthoquinone with aminophenols: evidence for hydroxy benzophenoxazine intermediate and antibacterial activity
【24h】

Reactions of 2,3-dichloro-1,4-naphthoquinone with aminophenols: evidence for hydroxy benzophenoxazine intermediate and antibacterial activity

机译:2,3-二氯-1,4-萘醌与氨基酚的反应:羟基苯并苯并苯胺中间体和抗菌活性的证据

获取原文
获取原文并翻译 | 示例
           

摘要

Reactions of 2,3-dichloro-1,4-naphthoquinone with o/m and p-aminophenols are studied. It was shown that reaction with 2-aminophenol results in 6-chloro-12a-methoxy-7H-benzo[c]phenozaxine-5(12aH)-one (1a) as the major product along with (6-chloro-12a-hydroxy-7H-benzo[c]phenoxazine-5(12aH)-one) (1b) in minor proportions. A major 6-chloro-12a-methoxy-9-methy1-7H-benzo[c]phenoxazin-5(12aH)-one (2a) was isolated from the 4-methyl-2-aminophenol whereas reactions with 3-aminophenol and 4-aminophenol yield products 2-(3-hydroxyphenylamino)-3-chloro-1,4-naphthoquinone (3) and 2-(4hydroxyphenylamino)-3-chloro-1,4-naphthoquinone (4). The hydroxy phenoxazine (1b) was obtained as the minor product which is evident from the single crystal X-ray diffraction studies. Pharmacological potential of these compounds have been evaluated against pathogenic Gram positive and Gram negative bacteria. These derivatives demonstrated broad spectrum of biological activity against all bacterial isolates with the MIC bring in the range of 4-512 mu g/ml. The relatively high MICs were observed compared to the reference antibiotics used. Except lb rest of the other compounds exhibit considerably lower MICs (32-512 mu g/ml), against the two Pseudomonas spp. and relatively high resistance towards reference antibiotics (with the MIC being 1024 mu g/ml). It has been shown that that synergistic action of phenoxazine derivatives in mixing with conventional antibiotics can be explored for treatment of pathogens. (C) 2018 Elsevier B.V. All rights reserved.
机译:研究了2,3-二氯-1,4-萘醌与O / M和对氨基苯酚的反应。结果表明,与2-氨基苯酚的反应导致6-氯-12a-甲氧基-7h-苯并[c]苯噻吩-5(12ah) - 作为主要产物以及(6-氯-12a-羟基) -7H-苯并[C]苯氧嘧啶-5(12AH) - 次少量比例中的1B)。从4-甲基-2-氨基苯酚中分离出主要的6-氯-12a-甲氧基-9-甲基-7H-苯并[c]苯氧基-5(12ah) - One(2a),而3-氨基苯酚和4个反应 - 氨基酚产量产物2-(3-羟基苯氨基)-3-氯-1,4-萘醌(3)和2-(4羟基苯基氨基)-3-氯-1,4-萘醌(4)。获得羟基苯恶嗪(1B)作为从单晶X射线衍射研究中明显明显的次要产物。已经评估了这些化合物的药理潜力针对致病素呈致病素阳性和革兰氏阴性细菌评估。这些衍生物对所有细菌分离株的基础生物活性表现出广谱,MIC引起4-512μg/ ml的范围。与使用的参考抗生素相比,观察到相对较高的麦克风。除了LB的剩余物体外,其他化合物的表现出相当低的麦克风(32-512μg/ ml),对抗两种假单胞菌SPP。对参考抗生素的相对高的耐受性(MIC为& 1024 mu g / ml)。已经证明,可以探索苯氧嗪衍生物在与常规抗生素混合中混合的协同作用以治疗病原体。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号